Furthermore, p53 also interacts with Wnt/β-catenin signaling, which prevents T cell migration into tumor tissues mediated by DCs, and modulation of the Wnt/β-catenin signaling pathway via p53 is considered an attractive therapeutic target [20–22]. The gene discussed is TP53; the disease is neoplasm.